TIP857: S&P Global, Novo, Deckers Brands w/ Stig Brodersen, Tobias Carlisle, & Hari Ramachandra
Nov 1, 2026 · 1h 27m
More Business podcasts
Summary
In this episode, Stig Brodersen joins value investors Tobias Carlisle and Hari Ramachandra to pitch three stocks the market has fallen out of love with. Hari argues that Novo Nordisk is undervalued at 12x earnings despite competition from Eli Lilly, while Stig highlights S&P Global as a high-quality, moat-protected business with overblown AI disruption risks. Finally, Toby presents Deckers, the owner of Hoka and UGG, as a classic value pick trading at 11x earnings with significant net cash.
Topics discussed
Introduction and episode overview
Novo Nordisk pitch: Background and market position
Novo Nordisk: Valuation, risks, and pipeline
Novo Nordisk: Competitive dynamics and innovation
Sponsor breaks and AI regulation discussion
S&P Global pitch: Business model and segments
S&P Global: Risks, AI disruption, and valuation
S&P Global: Insider buying and closing thoughts
Deckers pitch: Business overview and capital allocation
Deckers: Competitors, brand loyalty, and scenarios
Deckers: Risks, tariffs, and final valuation
Closing remarks and sign-off
More from The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
Listen ad-free on Castria